Position Overview

The Sr. Principal Medical Development Director, Breast Portfolio, will be responsible for clinical and translational leadership in the development and execution of the company’s precision oncology strategies; including, but not limited to, the design and implementation of next-generation sequencing (NGS) based assays, focused on the development, validation, and regulatory approval of diagnostic tests designed to help determine the most appropriate therapies for breast cancer patients, monitor therapy effectiveness, and detect the presence of residual disease.

In partnership with the Product and Medical Strategy teams, this role will provide medical leadership during the design, implementation, and reporting of studies that support pipeline products and/or line extensions to on-market products. This position will develop external relationships with oncology leaders at academic institutions, cooperative groups, and research organizations, identifying inv...